Product Information
RAMIPRIL 1.25 MG CAPSULE is a generic product labeled by BluePoint Laboratories, priced at $0.0834 per EA under NDC 68001042800. Its NADAC has been published 319 times since Jul 15, 2020.
FDA first approved this application on Jun 8, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001042800
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA091604FDA Approved
6/8/2011
TE Code
AB
On Market Since
2/28/2020
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 1.25 MG CAPSULE has been published 319 times since Jul 15, 2020, and over the history we have for it it has declined 23.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0834 per EA |
|---|---|
| All-time high | $0.1631 (Dec 16, 2020) |
| All-time low | $0.0626 (Jul 17, 2024) |
| 52-week high | $0.0989 |
| 52-week low | $0.0778 |
| Median price | $0.0970 |
| Average price | $0.1011 |
| Largest weekly change | +82.1% (Mar 20, 2024) |
| Weeks tracked | 319 |
| Tracking since | Jul 15, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RAMIPRIL 1.25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 1.25 MG CAPSULE, manufactured by BluePoint Laboratories, is $0.0834 per EA (NDC 68001042800), effective Aug 19, 2026.
How has the price of RAMIPRIL 1.25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 1.25 MG CAPSULE has declined 23.1%. It has been tracked across 319 weekly CMS publications since Jul 15, 2020.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 1.25 MG CAPSULE?
Since Jul 15, 2020, the NADAC for RAMIPRIL 1.25 MG CAPSULE has ranged from a low of $0.0626 (Jul 17, 2024) to a high of $0.1631 (Dec 16, 2020), with a median of $0.0970 per EA.
Are there cheaper alternatives to RAMIPRIL 1.25 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RAMIPRIL 1.25 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RAMIPRIL 1.25 MG CAPSULE?
RAMIPRIL 1.25 MG CAPSULE (NDC 68001042800) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.